Filter Results:
(207)
Show Results For
- All HBS Web
(332)
- People (1)
- News (59)
- Research (207)
- Events (1)
- Multimedia (1)
- Faculty Publications (99)
Show Results For
- All HBS Web
(332)
- People (1)
- News (59)
- Research (207)
- Events (1)
- Multimedia (1)
- Faculty Publications (99)
Sort by
- January 2017 (Revised March 2017)
- Case
Royal DSM: From Continuous Transformation to Organic Growth
By: William W. George, Carin-Isabel Knoop and Amram Migdal
Royal DSM CEO Feike Sijbesma was pondering the challenges of shifting DSM’s global organization from the constant transformations of the past 100 years to creating organic growth. When Sijbesma took the helm as CEO in 2007, he further pushed and completed the company’s... View Details
Keywords: Organic Growth; Organizational Change; M＆A; Mergers And Acquisitions; Divestment; Business Ventures; Business Divisions; Business Growth and Maturation; Restructuring; Change; Change Management; Transformation; Transition; Engineering; Chemicals; Mining; Ethics; Values and Beliefs; Finance; Capital Markets; Financial Markets; Food; Globalization; Global Strategy; Globalized Firms and Management; Globalized Markets and Industries; Health; Nutrition; History; Leadership; Leadership Development; Leadership Style; Leading Change; Management; Business or Company Management; Growth and Development Strategy; Growth Management; Management Practices and Processes; Management Style; Organizations; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Change and Adaptation; Organizational Culture; Organizational Design; Ownership; Public Ownership; Performance; Strategy; Adaptation; Consolidation; Corporate Strategy; Value; Value Creation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Europe; Netherlands
George, William W., Carin-Isabel Knoop, and Amram Migdal. "Royal DSM: From Continuous Transformation to Organic Growth." Harvard Business School Case 317-063, January 2017. (Revised March 2017.)
- 13 Oct 2009
- Research & Ideas
7 Lessons for Navigating the Storm
CEO Dan Vasella made counterintuitive moves by expanding Novartis's generic drug, vaccines, and consumer health businesses in spending heavily on acquisitions to offer alternatives to patented drugs. Meanwhile, he focused Novartis's View Details
Keywords: by Martha Lagace
- 15 Jun 2007
- Research & Ideas
Remembering Alfred Chandler
Chemical and Pharmaceutical Industries. In his lifetime, he produced a range of books, edited collections, and articles covering railways, management, global competition, anthracite coal, the career of Alfred P. Sloan, the nature of... View Details
Keywords: by Sean Silverthorne
- Research Summary
Overview
By: Andy Wu
How can technology entrepreneurs build competitive advantage from the ground up? Professor Andy Wu conducts scholarly research and develops course materials that document how technology entrepreneurs can (1) organize for innovation to create new market opportunities... View Details
Keywords: Strategy; Entrepreneurship; Venture Capital; Growth Management; Organizational Design; Organizational Structure; Technology Platform; Technological Innovation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; China; Southeast Asia; South Asia
- 10 Sep 2008
- Research & Ideas
Long-Tail Economics? Give Me Blockbusters!
you can make money in many creative industries by selling specialized products to niche markets identified via the Internet. For example, the new CEO of GlaxoSmithKline, the pharmaceuticals giant, likens the search for blockbusters to... View Details
- 12 Dec 2022
- Research & Ideas
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
Moderna, a pharmaceutical company, announced in September 2020 that it would slow enrollment of its COVID-19 vaccine trials to better improve representation. The majority of study participants were white, although COVID-19 was... View Details
- 15 Sep 2009
- First Look
First Look: September 15
generation moving up the corporate ranks. Stimulate Creativity by Fueling Passion Authors:Teresa Amabile and Colin M. Fisher Publication:In The Blackwell Handbook of Principles of Organizational Behavior. 2nd ed. London: Wiley-Blackwell,... View Details
Keywords: Martha Lagace
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
specified stage of development. It would throw the ball over the fence [to a major pharmaceutical firm] and it would sit around and wait. Sooner or later, if the product was successful, it would collect some royalties." Now, a... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
as 1994: That year was known among insiders as "The Year of the Placebo." What The Data Says The good news: One hundred thirty drugs can be traced to biotech, said Pisano. (For purposes of discussion during his presentation, he defined "biotech" as... View Details
- 28 Apr 2009
- First Look
First Look: April 28, 2009
market, the by-product market. Since waste is now a useful raw material, the firm may increase profit by generating more "waste." By converting waste into by-product, the firm not only reduces waste disposal cost and increases... View Details
Keywords: Martha Lagace
- 27 Jun 2005
- Research & Ideas
The Potential Downside of Win-Win
the negotiation. In April 2001, the FTC filed a complaint accusing pharmaceutical companies Schering-Plough and Upsher-Smith of restricting trade. Upsher-Smith had been preparing to introduce a generic View Details
Keywords: by Max H. Bazerman
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
Until the close of the last decade, health consumers received much of their knowledge and advice about prescription drugs from their physicians or other health care professionals. Today, pharmaceutical companies are spending several... View Details
Keywords: by Manda Salls
- 30 Jun 2003
- Research & Ideas
Computer Security is For Managers, Too
each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research servers that hold data on... View Details
- 12 Mar 2014
- Research & Ideas
Entrepreneurship and Multinationals Drive Globalization
systems conducive to modern entrepreneurship. The particular focus in this book is why multinational firms were not better transferors of innovation and entrepreneurial capabilities from the West to the Rest. The historical evidence makes clear that multinationals in... View Details
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
I see in open source. People often think about open source as a special case as if such openness can only happen in software, and this is an attempt to work on generalizing what we see. Q: What is different about problem solving in the... View Details
Keywords: by Martha Lagace
- 21 Nov 2006
- First Look
First Look: November 21, 2006
heterogeneity is both generative and occasionally confusing. We identify three distinct areas of research that provide insight into how teams learn to stimulate cross-area discussion and future research. We find that scholars have made... View Details
Keywords: Sean Silverthorne
- 22 Apr 2014
- First Look
First Look: April 22
Experimental Psychology: General The (Perceived) Meaning of Spontaneous Thoughts By: Morewedge, Carey K., Colleen E. Giblin, and Michael I. Norton Abstract—Much human thought arises unbidden, spontaneously intruding upon consciousness.... View Details
Keywords: Sean Silverthorne
- 19 Dec 2005
- Research & Ideas
The Regional Slice of Your Global Strategy
for gasoline in the United States to consist of five distinct regions. Other large markets where transport costs are relatively high in relation to product value, such as cement in Brazil or beer in China, can be similarly broken down. The View Details
Keywords: by Pankaj Ghemawat
- 03 Jan 2017
- First Look
January 3, 2017
silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For new precision therapies to be developed, these data sets need to be shared broadly. Patients can help lead this effort by... View Details
Keywords: Carmen Nobel